Related Experiment Video
Updated: May 31, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Relationship between serum thymosin β4 levels and coronary collateral development.
Shumin Lv1, Gang Cheng, Yifei Xu
1Department of Cardiology, the Second Affiliated Hospital, Zhejiang University College of Medicine, China.
Coronary Artery Disease
|June 22, 2011
Summary
Elevated serum thymosin beta-4 levels are linked to better coronary collateral formation in patients with coronary artery disease. This finding suggests thymosin beta-4 (Tβ4) may play a role in cardiovascular health.
Area of Science:
- Cardiovascular Biology
- Angiogenesis Research
- Biomarker Discovery
Background:
- Thymosin beta-4 (Tβ4) is recognized for its potential to stimulate blood vessel growth (angiogenesis and arteriogenesis).
- The association between serum Tβ4 levels and coronary collateral development in patients with coronary artery disease (CAD) remains largely unexplored.
Purpose of the Study:
- To investigate whether serum Tβ4 levels independently predict the formation of coronary collaterals in patients diagnosed with CAD.
- To explore the relationship between Tβ4 levels and the extent of collateral circulation in CAD patients.
Main Methods:
- A cohort of 190 consecutive patients undergoing coronary angiography were categorized into "poor collateral" (103 patients) and "good collateral" (87 patients) groups based on stenosis severity and visible collateral circulation.
- Collateral circulation was quantitatively assessed using the Cohen-Rentrop classification system.
Main Results:
- Patients with good collateral circulation exhibited significantly higher serum Tβ4 levels (1373.00 ± 1082.88 ng/ml) compared to those with poor collateral circulation (1024.50 ± 516.92 ng/ml).
- Multivariable logistic regression analysis confirmed that serum Tβ4 levels were a strong independent predictor of the collateral Cohen-Rentrop score (OR=1.00, P=0.035).
Conclusions:
- Elevated serum Tβ4 levels are independently associated with enhanced coronary collateralization in patients with CAD.
- Higher serum Tβ4 concentrations correlate with better-developed collateral circulation, highlighting Tβ4's potential role in cardiovascular adaptation.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...